Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens. [electronic resource] by
- Kline, Christina Leah B
- Schiccitano, Angelique
- Zhu, Junjia
- Beachler, Cheryl
- Sheikh, Hassan
- Harvey, Harold A
- Mackley, Heath B
- McKenna, Kevin
- Staveley-O'Carroll, Kevin
- Poritz, Lisa
- Messaris, Evangelos
- Stewart, David
- Sivik, Jeffrey
- El-Deiry, Wafik S
Producer: 20150102
In:
Clinical colorectal cancer vol. 13
Availability: No items available.
|